Ipramid (Simvastatin)

Simvastatin inhibits the enzyme HMG‑CoA reductase in the liver, the key step in cholesterol synthesis. By blocking this pathway, the drug reduces intracellular cholesterol, leading to an increase in LDL‑receptor expression on hepatocytes, which enhances removal of LDL‑cholesterol from the bloodstream.

The specific dose of Ipramid is determined by the prescribing healthcare professional based on the patient’s lipid profile, cardiovascular risk, and individual tolerance. Dosage adjustments are made according to clinical response and laboratory monitoring, and patients should follow the prescriber’s instructions precisely.

Ipramid (Simvastatin) is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because of potential fetal harm. It is also not recommended for breastfeeding mothers, as it may pass into breast milk and affect the infant. Alternative lipid‑lowering strategies should be considered in these situations.

To place an order, visit the product page for Ipramid on the GNH India website (gnhindia.com) and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and necessary import documentation.

Ipramid (Simvastatin) is a widely used statin with a well‑established efficacy profile for lowering LDL‑cholesterol. Compared with newer, more potent statins such as rosuvastatin or atorvastatin, Simvastatin may require higher doses to achieve similar lipid reductions, but it remains cost‑effective and is supported by extensive clinical data.

Ipramid should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight. Do not store in the bathroom or near a kitchen sink where humidity is high.

Ipramid is taken orally, usually once daily in the evening, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and can be taken with or without food, unless the prescriber advises otherwise.

The most serious risks include rhabdomyolysis, a severe form of muscle breakdown that can lead to kidney failure, and significant liver injury indicated by marked elevations in liver enzymes. Patients should promptly report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction such as jaundice.

Ipramid should not be used by individuals with active liver disease, unexplained persistent elevations of hepatic transaminases, or those who are pregnant or planning pregnancy. It is also contraindicated in patients taking strong CYP3A4 inhibitors, such as certain antifungals or antibiotics, without appropriate medical supervision.